Towards Healthcare
Anticoagulation Monitoring Devices Market Grows USD 3.13 Bn by 2034

Anticoagulation Monitoring Devices Market North America Leads, Asia Pacific to See Fastest Regional Growth by 2034

According to market projections, the global anticoagulation monitoring devices market, valued at USD 1.55 billion in 2024, is anticipated to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% over the next decade.Rising geriatric population across the globe, rising adoption of novel oral anticoagulants (NOACs), and growing prevalence of chronic disease are driving the growth of the market. North America dominated the global anticoagulation monitoring devices market, while Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.

Content

  • Insight Code: 5947
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

These devices include pointofcare systems for PT INR, ACT, and aPTT testing, enabling rapid assessment of blood clotting parameters. They are critical for managing anticoagulant therapy and tailoring treatment decisions in clinical and home settings.

Surging prevalence of cardiovascular conditions requiring anticoagulation, combined with increasing use of both traditional and direct oral anticoagulants, fuels demand. A trend toward decentralizing testing into hospitals, clinics, and home care accelerates adoption.

PTINR (anticoagulation) devices dominate usage, especially for warfarin monitoring. ACT aPTT devices serve critical care and surgery, while viscoelastic monitors are preferred in highrisk surgical and ICU settings.

High device and consumable costs, along with reimbursement uncertainty, limit broader use. However, increased smartphone EHR connectivity and remote patient monitoring offer growth potential in homebased anticoagulation care.

North America holds the largest share thanks to strong infrastructure and reimbursement frameworks. Meanwhile, Asia Pacific is the fastest-growing region, driven by rising cardiovascular burden and expanding access to diagnostics.

As of 2024, the anticoagulation monitoring devices market is valued at USD 1.55 billion. It is projected to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 to 2034.

As of 2024, the anticoagulation monitoring devices market is valued at USD 1.55 billion. It is projected to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 to 2034.

As of 2024, the anticoagulation monitoring devices market is valued at USD 1.55 billion. It is projected to reach USD 3.13 billion by 2034, growing at a CAGR of 7.24% from 2025 to 2034.
Any Questions